SOLIGENIX, INC. — Director's Dealing 2009

Oct 8, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX.OB)
CIK: 0000812796
Period of Report: 2009-09-28

Reporting Person: Biotex Pharma Investments, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-09-28	Common Stock	D	250000	$.262	Disposed	18750000	Direct
2009-10-01	Common Stock	D	750000	$.3087	Disposed	18000000	Direct